Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 28, 2020
GRAM has entered into an agreement with Janssen to support the manufacture of its SARS-CoV-2 vaccine candidate.
read more
Grand River Aseptic Manufacturing (GRAM) completed its major $60 million expansion project and recently took occupancy.
read more
Grand River Aseptic Manufacturing (GRAM) has implemented its fully-automated serialization and aggregation processes for commercial injectable drug products.
read more
Wednesday, August 24, 2022
GNS and Servier announced a collaboration to advance drug discovery, translational, and clinical development efforts in Multiple Myeloma (MM).
read more
FDA issued a guidance entitled, “Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Manufacturing.”
read more
Wednesday, April 25, 2012
ISPE announced today that it has brought together a substantial line-up of global regulatory officials and pharmaceutical industry leaders to be plenary speakers at the FDA/ISPE co-sponsored “Redefining the ‘C’ in ‘CGMP’” Conference in Baltimore, Md....
read more
Glenmark Pharmaceuticals and Harbour BioMed have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and commercialize GBR 1302.
read more
Monday, December 23, 2019
Glenmark Pharmaceutical announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, to the consumer level.
read more
Glenmark Pharmaceuticals has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma.
read more
GlaxoSmithKline’s Sligo plant will close the plant and lay off its 165 workers over the next three years.
read more
Delpharm, will acquire GlaxoSmithKline’s Poznan manufacturing facility in Poland.
read more
Monday, December 30, 2019
Gilead Sciences and Eisai announced the two companies have entered into an agreement for the distribution and co-promotion of filgotinib, pending regulatory approval for rheumatoid arthritis.
read more
Tuesday, November 08, 2022
Global Healthcare Opportunities, or GHO Capital Partners LLP and The Vistria Group announced that they have entered into a definitive agreement to acquire a controlling interest in Alcami Corporation from funds affiliated with Madison Dearborn ...
read more
Wednesday, January 22, 2020
GHO has acquired Ardena, a specialist CDMO focused on early phase drug development.
read more
Gerresheimer announced investments to rapidly expand manufacturing, supply and logistics capacity for glass vials in the U.S. The project will be supported by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of ...
read more